Mediators of the effects of canagliflozin on heart failure in patients with type 2 diabetes
<p><strong>Objectives</strong> The purpose of this study was to explore potential mediators of the effects of canagliflozin on heart failure in the CANVAS Program (CANagliflozin cardioVascular Assessment Study; NCT01032629 and CANagliflozin cardioVascular Assessment Study–Renal; NC...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Elsevier
2019
|